Blue Shield of California members may have had their data exposed in a November data breach. Information included member names, dates of birth, addresses, subscriber IDs, social security numbers, and vision related treatment details. The company has offered no-cost credit monitoring and identity restoration services to affected members. It is the latest company to suffer a health data breach, with the healthcare industry experiencing the greatest financial impact, averaging $10.9 million in costs per breach.
FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen Med
Viridian Therapeutics’ Lumvoa is approved for treating both the chronic and active phases of thyroid eye disease. This drug will offer patients an alternative to
